{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2(2)"],"submitter":["Shoer S"],"pubmed_abstract":["<h4>Background</h4>The gold standard for COVID-19 diagnosis is detection of viral RNA through PCR. Due to global limitations in testing capacity, effective prioritization of individuals for testing is essential.<h4>Methods</h4>We devised a model estimating the probability of an individual to test positive for COVID-19 based on answers to 9 simple questions that have been associated with SARS-CoV-2 infection. Our model was devised from a subsample of a national symptom survey that was answered over 2 million times in Israel in its first 2 months and a targeted survey distributed to all residents of several cities in Israel. Overall, 43,752 adults were included, from which 498 self-reported as being COVID-19 positive.<h4>Findings</h4>Our model was validated on a held-out set of individuals f"],"journal":["Med (New York, N.Y.)"],"pagination":["196-208.e4"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7547576"],"repository":["biostudies-literature"],"pubmed_title":["A Prediction Model to Prioritize Individuals for a SARS-CoV-2 Test Built from National Symptom Surveys."],"pmcid":["PMC7547576"],"pubmed_authors":["Rossman H","Balicer R","Irony A","Kolobkov D","Castel N","Segal E","Shoer S","Lavon A","Godneva A","Hoch O","Shilo S","Zer-Aviv M","Spector T","Cohen O","Zohar AE","Kalka I","Hizi D","Keshet A","Karady T","Meir T","Shalev V","Sudre C","Kariv A","Geiger B","Gavrieli A"],"additional_accession":[]},"is_claimable":false,"name":"A Prediction Model to Prioritize Individuals for a SARS-CoV-2 Test Built from National Symptom Surveys.","description":"<h4>Background</h4>The gold standard for COVID-19 diagnosis is detection of viral RNA through PCR. Due to global limitations in testing capacity, effective prioritization of individuals for testing is essential.<h4>Methods</h4>We devised a model estimating the probability of an individual to test positive for COVID-19 based on answers to 9 simple questions that have been associated with SARS-CoV-2 infection. Our model was devised from a subsample of a national symptom survey that was answered over 2 million times in Israel in its first 2 months and a targeted survey distributed to all residents of several cities in Israel. Overall, 43,752 adults were included, from which 498 self-reported as being COVID-19 positive.<h4>Findings</h4>Our model was validated on a held-out set of individuals f","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Feb","modification":"2025-05-29T22:30:52.252Z","creation":"2025-05-29T22:30:52.252Z"},"accession":"S-EPMC7547576","cross_references":{"pubmed":["33073258"],"doi":["10.1016/j.medj.2020.10.002"]}}